UK evidence-led drug information
UK Drug Trends Intelligence ↗TD Consultancy ↗
Drug emergency? If someone is unconscious, having a seizure, severely confused or not breathing normally, call 999.
Empathogen / stimulantUK guide

MDMA

MDMA is an empathogenic stimulant usually sold as tablets or crystals/powder. Products sold as ecstasy vary in content and strength, and a logo or colour cannot identify what is present.

Reviewed 5 August 2026Legal information checked 5 August 2026Responsible organisation TD Consultancy
Anonymous muted-colour pressed tablets without imprints arranged on a light background to represent MDMA products

Appearance varies. A substance cannot be reliably identified by colour, shape, packaging or an image.

Overview

What is MDMA?

Common and street names

ecstasy · Mandy · MD · molly

Drug category

Empathogen / stimulant

Forms and appearance

Usually sold as pressed tablets or crystals/powder. Tablet logos, shape and colour change frequently and do not identify contents or strength.

How it is commonly used

MDMA is most often swallowed as a tablet/capsule or powder/crystal. Products vary widely, and this guide does not provide dose targets.

Brain & body

How MDMA affects signalling and behaviour

MDMA increases signalling from serotonin, noradrenaline and dopamine, with serotonin especially prominent. These changes influence mood, social connection, arousal, temperature regulation and water balance.

Effects & risks

What people may experience — and what can go wrong

Commonly reported effects

  • Increased energy
  • Empathy or emotional closeness
  • Heightened sensory experience
  • Increased heart rate, temperature and jaw tension

Short-term risks

  • Overheating
  • Water/sodium imbalance
  • Serotonin toxicity in some combinations
  • Cardiovascular strain, panic or confusion

Longer-term risks

  • Sleep and mood disruption after repeated use
  • Escalating exposure as effects become less predictable
  • Possible memory or concentration difficulties with heavy frequent use
  • Harms shaped by adulterants or unexpected contents

Mental-health effects

MDMA can be followed by low mood, irritability or anxiety. Panic, confusion or severe agitation can occur during toxicity. Therapeutic research uses screened participants, controlled dosing and clinical supervision and should not be equated with non-medical use.

Dependence, tolerance & withdrawal

Repeated use can change the pattern

MDMA is not typically associated with the same physical withdrawal syndrome as alcohol or benzodiazepines, but repeated use, craving and problematic patterns can develop.

Mixing drugs

Interaction risks to know

01

MDMA + serotonergic medicines can raise serotonin-toxicity concerns; seek specialist medical advice rather than self-adjusting prescribed medicine.

02

MDMA + other stimulants increases cardiovascular and overheating strain.

03

MDMA + alcohol can worsen dehydration, impairment and cardiovascular load.

No combination is labelled safe.

The absence of a recorded interaction does not mean that a combination is safe. Strength, dose, health, tolerance, contamination and other substances can alter risk.

Check another combination

Harm reduction

Practical ways to reduce risk

1

Do not use a pill logo or colour as a dose guide.

2

Avoid combining with other stimulants or serotonergic drugs.

3

Take regular breaks from heat and physical exertion.

4

If on prescribed medicine, do not stop or alter it to take MDMA without medical advice.

Harm reduction can reduce some risks; it cannot make an unregulated drug, dose or combination risk-free.

Emergency

When to call 999

  • Very high temperature with confusion
  • Seizure
  • Collapse, chest pain or severe agitation
  • Reduced consciousness
If in doubt in a suspected drug emergency, call 999 and describe what you can see. Do not wait for certainty about the substance.

Treatment & support

Help does not require one fixed recovery goal

UK drug and alcohol services can assess physical health, mental health, dependence, risk, housing and support needs, then agree a plan with the person. Goals may include immediate harm reduction, stabilisation, reduction or stopping use.

MDMA is not typically associated with the same physical withdrawal syndrome as alcohol or benzodiazepines, but repeated use, craving and problematic patterns can develop.

Brief history

How we got here

MDMA was first synthesised in the early twentieth century and became associated with psychotherapy research before entering dance and club cultures. Criminalisation, changing purity, high-strength tablets and renewed therapeutic research have shaped its modern history.

Read the history guide

Key facts & misconceptions

Three useful corrections

01

'Molly' or crystal appearance does not prove purity.

02

More water is not always safer; excessive water can also be dangerous.

03

Clinical MDMA research does not establish non-medical use as safe.

Frequently asked questions

Quick answers

What type of drug is MDMA?

MDMA is described here as empathogen / stimulant. Some drugs cross categories, and mixtures may contain more than one drug type.

Can MDMA be identified by appearance?

No. Appearance, packaging, a logo or colour cannot reliably establish identity, strength or contamination.

When should I call 999?

Call 999 for a suspected drug emergency, including reduced consciousness, abnormal breathing, seizure, severe chest pain or severe confusion. Very high temperature with confusion

Evidence & governance

Sources and review

Responsible organisation: TD Consultancy
Published: 5 August 2026 · Last reviewed: 5 August 2026
Next formal review: February 2027, or earlier if material safety or legal information changes.

Evidence on illicit drug composition and emerging markets can change quickly. Legal status can be compound- and preparation-specific. Links below are prioritised to current official UK guidance.